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1 Introduction
The Diabetes Treatment Satisfaction Questionnaire
(DTSQ) is a widely used measure (in 20+ languages) of
patient satisfaction with treatment (1, 2). The DTSQ is
often, perhaps misleadingly, referred to as a quality of life
(QoL) indicator.
The Audit of Diabetes-Dependent Quality of Life (ADDQoL)
was designed to have a broader focus on the impact of
diabetes on QoL, taking into account the relevance,
importance and impact of diabetes on life domains (3).
Similarities and differences between the DTSQ and
ADDQoL are here investigated to assess their suitability for
evaluating new treatment regimens.
Speight J and Bradley C (2000)  ADDQoL indicates negative impact of diabetes on quality of life despite high 
levels of satisfaction with treatment. Diabetologia, 43: [Suppl1]: I-IV, A225. 
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2 The Measures
DTSQ
 6 Treatment Satisfaction items:
 rated: 0 (‘very dissatisfied’) to 6 (‘very satisfied’)
 summed scores produce a total Treatment Satisfaction score
(range: 0 to 36)
 2 remaining items are treated individually:
 item 2: perceived frequency of hyperglycaemia
 item 3: perceived frequency of hypoglycaemia
 both rated: 0 (‘none of the time’) to 6 (‘most of the time’)
 2 overview items:
 generic ‘present QoL’
 diabetes-specific ‘impact of diabetes on QoL’
 both scored on a scale of -3 (extremely bad present QoL or
negative impact of diabetes on QoL) to +3 (excellent present
QoL or positive impact of diabetes on QoL)
ADDQoL
3 Method
The DTSQ and ADDQoL were used in DIABQoL+ (4), a
study of 795 patients at one of two UK hospital diabetes
clinics. Patients were given questionnaires by a nurse at
the time of their annual review, with a pre-paid envelope
for return.
4 Results
Correlation of DTSQ with ADDQoL
The ADDQoL AWI score showed an expected small but
significant correlation with the DTSQ Treatment
Satisfaction score (r=0.25, p<0.001). Despite high levels
of Treatment Satisfaction (mean 27.76, sd 6.47), the
ADDQoL AWI score indicated negative impact of diabetes
on QoL (mean -1.96, sd 1.71).
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DTSQ ADDQoL
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In preparation:
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 18 domain-specific items:
 concern the impact of diabetes on specific aspects of life
 rated on a scale -3 (maximum negative impact) to +3
(maximum positive impact)
 weighted by the importance of each aspect of life for the
individual: rated 3 (very important) to 0 (not at all important)
 weighted impact scores range from -9 (maximum negative
impact of diabetes on QoL) to +9 (maximum positive impact
of diabetes on QoL)
 Average weighted impact (AWI) score: the sum of weighted
impact scores for each applicable aspect of life divided by the
number of applicable aspects of life (range: -9 to +9)
...continued overleaf 
 Fig 2a: Impact of complications on QoL 2
Sig: *p< 0.05 ,  **p<0.01 ,  ***p<0.001
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Fig 2b: Impact of complications on satisfaction 2
Sig: *p<0.0 5,  **p<0.0 1,  ***p<0.001
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6 Conclusions
 DTSQ showed high levels of Treatment Satisfaction
despite perceived negative impact of diabetes on QoL.
 ADDQoL was more sensitive to differences in treatment
and complications even though DTSQ is commonly found
to be sensitive to treatment changes in clinical trials.
 ADDQoL has even more scope than DTSQ for showing
improvements following treatment change.
 Treatments that increase dietary freedoms without loss of
diabetes control will have marked benefits for individuals’
QoL.
AWI showed more negative impact of diabetes on QoL for
insulin-treated than for non-insulin-treated patients (p<0.01)
but Treatment Satisfaction did not differ [see Fig.s 1a & 1b].
Impact of treatment
People with complications reported greater negative impact
of diabetes on QoL than did those without (p<0.001) and
less Treatment Satisfaction (p<0.05) [see Fig.s 2a & 2b].
Impact of complications
Fig 1a: Impact of treatment on QoL 1
Sig: *p<0.0 5,  **p<0.0 1,  ***p<0.001
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Fig 1b: Impact of treatment on satisfaction 1
Sig: *p<0.05 ,  **p<0.01 ,  ***p<0.001
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5 Discussion
There was an expected small but significant correlation
between ADDQoL and DTSQ scores, suggesting the two
instruments are measuring related but different constructs.
High levels of Treatment Satisfaction were observed
despite patients, on average, reporting that diabetes had a
negative impact on their QoL.
The DTSQ has shown sensitivity to changes in treatment in
many multi-national clinical trials. However, the ADDQoL is
here shown to be even more sensitive to differences in
treatment and complications than the DTSQ. As the
ADDQoL identifies more negative psychological outcomes,
it has even more scope for showing improvements
following treatment change.
ADDQoL domain scores indicate that, on average,
‘freedom to eat as I wish’ is the aspect of life most
negatively impacted by diabetes, regardless of treatment.
New treatments that minimise dietary restrictions without
loss of glycaemic control will have marked benefits for QoL.
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2 ANCOVA was performed to covary the effects of treatment: significances
were reduced slightly but most differences remained significant.
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